Breaking

Bristol Myers Squibb recently filed a lawsuit against the Department of Health and Human Services (HHS), claiming that the Biden administration is unlawfully preventing the company from using rebates to pay hospitals involved in...

Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs to be passed by Congress by December to avoid obstacles,...

In recent years, Trump's health policies have sparked significant debate among healthcare professionals, highlighting crucial health policy differences compared to previous administrations. This guide examines the unique aspects of Trump Administration healthcare, focusing on...

President-elect Trump has selected biotech investor Jim O'Neill as the nominee for deputy secretary of the Health and Human Services department. If confirmed, O'Neill would be responsible for overseeing the day-to-day operations of various...

President-elect Trump has made his selection for the role of leading the National Institutes of Health known, with Stanford University professor Jay Bhattacharya being chosen for the position, as announced by his transition team...

The impact of artificial intelligence (AI) on radiologists' burnout has been a topic of recent discussion. A study conducted in China involving over 6,700 radiologists revealed a surprising result - the use of AI...

The Biden administration recently announced a series of proposed changes to private Medicare plans aimed at improving coverage, regulating the use of artificial intelligence, and ensuring access to behavioral health providers and additional benefits....

Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...

Alector Therapeutics announced that their Phase 2 trial for a potential Alzheimer's antibody, known as AL002, was unsuccessful. This setback is disappointing as the drug was considered a promising approach to treating the neurodegenerative...

The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be no more effective than a placebo in a large clinical...

President Trump's recent decision to nominate Robert F. Kennedy Jr. as the secretary of the Department of Health and Human Services has caused quite a stir in the health care sector. In this analysis,...

The United States is facing an uncertain future when it comes to vaccine policy. With potential appointees like Robert F. Kennedy Jr., Mehmet Oz, Jay Bhattacharya, and Joseph A. Ladapo, public health advocates are...